Exploring genetic variations that may be associated with the direct effects of some antipsychotics on lipid levels-Reference-Cited by-同舟云学术

Exploring genetic variations that may be associated with the direct effects of some antipsychotics on lipid levels

Published:2008-01 Issue:1-3 Volume:98 Page:40-46
ISSN:0920-9964
Container-title:Schizophrenia Research
language:en
Short-container-title:Schizophrenia Research

Author:

de Leon Jose,Correa Juan Carlos,Ruaño Gualberto,Windemuth Andreas,Arranz Maria J.,Diaz Francisco J.

Publisher

Elsevier BV

Subject

Biological Psychiatry,Psychiatry and Mental health

Reference19 articles.

1. Categorical Data Analysis;Agresti,1990

2. Planning for the optimal design of studies to personalize antipsychotic prescriptions in the post-CATIE era: the clinical and pharmacoepidemiological data suggest that pursuing the pharmacogenetics of metabolic syndrome complications (hypertension, diabetes mellitus and hyperlipidemia) may be a reasonable strategy;de Leon;Schizophr. Res.,2007

3. A clinical study of the association of antipsychotics with hyperlipidemia;de Leon;Schizophr. Res.,2007

4. Leptin and leptin receptor gene polymorphisms and increases in body mass index (BMI) from olanzapine treatment in persons with schizophrenia;Ellingrod;Psychopharmacol. Bull.,2007

5. Prevalence of the metabolic syndrome among US adults;Ford;JAMA,2002

Cited by 34 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Progress in Genetic Polymorphisms Related to Lipid Disturbances Induced by Atypical Antipsychotic Drugs;Frontiers in Pharmacology;2020-02-04

2. Relation of neuropeptide Y gene expression and genotyping with hypertension in chronic kidney disease;Biochemistry and Biophysics Reports;2019-09

3. Getting to precision psychopharmacology: Combining clinical and genetic information to predict fat gain from aripiprazole;Journal of Psychiatric Research;2019-07

4. Peculiarities of the Effect of Antipsychotics: Pharmacogenetic Studies;Human Physiology;2018-11

5. Impact of Genomics on Drug Discovery and Clinical Medicine;Genomics-Driven Healthcare;2018